142 related articles for article (PubMed ID: 27031712)
1. HIF-1--a big chapter in the cancer tale.
Ajduković J
Exp Oncol; 2016 Mar; 38(1):9-12. PubMed ID: 27031712
[TBL] [Abstract][Full Text] [Related]
2. Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms.
Korbecki J; Simińska D; Gąssowska-Dobrowolska M; Listos J; Gutowska I; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639040
[TBL] [Abstract][Full Text] [Related]
3. Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha.
Yun BD; Son SW; Choi SY; Kuh HJ; Oh TJ; Park JK
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575983
[TBL] [Abstract][Full Text] [Related]
4. Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer.
Chen J; Zhang M; Ma Z; Yuan D; Zhu J; Tuo B; Li T; Liu X
Cell Oncol (Dordr); 2021 Aug; 44(4):739-749. PubMed ID: 33856653
[TBL] [Abstract][Full Text] [Related]
5. Lipid metabolic reprogramming by hypoxia-inducible factor-1 in the hypoxic tumour microenvironment.
Seo J; Yun JE; Kim SJ; Chun YS
Pflugers Arch; 2022 Jun; 474(6):591-601. PubMed ID: 35348849
[TBL] [Abstract][Full Text] [Related]
6. HIF-1 at the crossroads of hypoxia, inflammation, and cancer.
Balamurugan K
Int J Cancer; 2016 Mar; 138(5):1058-66. PubMed ID: 25784597
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships.
Hielscher A; Gerecht S
Free Radic Biol Med; 2015 Feb; 79():281-91. PubMed ID: 25257256
[TBL] [Abstract][Full Text] [Related]
8. Advances in Hypoxia-Inducible Factor Biology.
Choudhry H; Harris AL
Cell Metab; 2018 Feb; 27(2):281-298. PubMed ID: 29129785
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor.
Mistry IN; Tavassoli A
ACS Synth Biol; 2017 Mar; 6(3):518-527. PubMed ID: 27978620
[TBL] [Abstract][Full Text] [Related]
10. Glucose Transporter 1-Mediated Transcytosis of Glucosamine-Labeled Liposomal Ceramide Targets Hypoxia Niches and Cancer Stem Cells to Enhance Therapeutic Efficacy.
Yu LY; Shueng PW; Chiu HC; Yen YW; Kuo TY; Li CR; Liu MW; Ho CH; Ho TH; Wang BW; Li CE; Chen MH; Shen YA; Lo CL
ACS Nano; 2023 Jul; 17(14):13158-13175. PubMed ID: 37436002
[TBL] [Abstract][Full Text] [Related]
11. The role of hypoxia-inducible factors in breast cancer stem cell specification.
Karami Fath M; Garousi S; Mottahedi M; Ghasemzadeh N; Salmani K; Olfati F; Beit Saeed M; Sotoudeh S; Barati G
Pathol Res Pract; 2023 Mar; 243():154349. PubMed ID: 36791562
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia and its effect on the cellular system.
Rahane D; Dhingra T; Chalavady G; Datta A; Ghosh B; Rana N; Borah A; Saraf S; Bhattacharya P
Cell Biochem Funct; 2024 Mar; 42(2):e3940. PubMed ID: 38379257
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factors: cancer progression and clinical translation.
Wicks EE; Semenza GL
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35642641
[TBL] [Abstract][Full Text] [Related]
14. The rise of viperin: the emerging role of viperin in cancer progression.
Weinstein AG; Godet I; Gilkes DM
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36519538
[TBL] [Abstract][Full Text] [Related]
15. Ultra-Small Platinum Nanoparticle-Enabled Catalysis and Corrosion Susceptibility Reverse Tumor Hypoxia for Cancer Chemoimmunotherapy.
Liao FH; Yao CN; Wu TH; Chen SP; Yeh LC; Lin SY; Lin WJ
ACS Appl Bio Mater; 2021 Aug; 4(8):6527-6538. PubMed ID: 35006885
[TBL] [Abstract][Full Text] [Related]
16. The interferon-inducible protein viperin controls cancer metabolic reprogramming to enhance cancer progression.
Choi KM; Kim JJ; Yoo J; Kim KS; Gu Y; Eom J; Jeong H; Kim K; Nam KT; Park YS; Chung JY; Seo JY
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36227691
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer.
Reang J; Sharma PC; Thakur VK; Majeed J
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439796
[TBL] [Abstract][Full Text] [Related]
18. Engineering Tools for Regulating Hypoxia in Tumour Models.
Kim MH; Green SD; Lin CC; Konig H
J Cell Mol Med; 2021 Aug; 25(16):7581-7592. PubMed ID: 34213838
[TBL] [Abstract][Full Text] [Related]
19. Role of Hypoxia in the Interferon Response.
Arnaiz E; Harris AL
Front Immunol; 2022; 13():821816. PubMed ID: 35251003
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal: Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia.
Zhang H; Bosch-Marce M; Shimoda LA; Tan YS; Baek JH; Wesley JB; Gonzalez FJ; Semenza GL
J Biol Chem; 2023 Aug; 299(8):105125. PubMed ID: 37556879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
